| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.09▼ | 3.09▼ | 3.10▼ | 3.25▼ | 2.85▲ |
| MA10 | 3.09▼ | 3.11▼ | 3.13▼ | 3.06▲ | 2.66▲ |
| MA20 | 3.09▼ | 3.15▼ | 3.20▼ | 2.86▲ | 2.91▲ |
| MA50 | 3.11▼ | 3.26▼ | 3.21▼ | 2.65▲ | 3.69▼ |
| MA100 | 3.13▼ | 3.20▼ | 2.93▲ | 2.88▲ | 3.93▼ |
| MA200 | 3.20▼ | 2.91▲ | 2.69▲ | 3.37▼ | 4.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.001▼ | -0.022▼ | 0.045▲ | 0.098▲ |
| RSI | 39.575▼ | 34.087▼ | 37.996▼ | 57.318▲ | 49.661▼ |
| STOCH | 29.144 | 45.883 | 28.203 | 64.740 | 54.992 |
| WILL %R | -76.923▼ | -75.000▼ | -85.294▼ | -51.698 | -35.584 |
| CCI | -155.556▼ | -77.239 | -84.320 | 33.134 | 162.535▲ |
|
Thursday, June 12, 2025 07:12 AM
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- Equity Insider News Commentary - The 2025 ASCO Annual ...
|
|
Thursday, June 12, 2025 06:09 AM
ImmunityBio’s Anktiva holds bladder cancer promise despite FDA hurdles, while its lymphopenia treatment could unlock major upside. Learn why IBRX stock is a buy.
|
|
Wednesday, June 11, 2025 05:00 PM
June 03, 2025--ImmunityBio, Inc. (NASDAQ: IBRX) today announced results presented at ASCO 2025 of the first known treatment for lymphopenia with ANKTIVA and CAR-NK therapy. This data supports that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.03 | 3.155 | 3.01 | 3.07 | 16,731,763 |
| 12/06/25 | 3.19 | 3.365 | 3.17 | 3.19 | 8,667,458 |
| 11/06/25 | 3.34 | 3.40 | 3.21 | 3.24 | 8,691,229 |
| 10/06/25 | 3.515 | 3.755 | 3.33 | 3.33 | 16,206,450 |
| 09/06/25 | 3.29 | 3.53 | 3.225 | 3.44 | 25,901,082 |
| 06/06/25 | 2.95 | 3.32 | 2.95 | 3.15 | 18,810,229 |
| 05/06/25 | 2.90 | 3.015 | 2.83 | 2.90 | 7,131,326 |
| 04/06/25 | 2.75 | 2.98 | 2.66 | 2.93 | 11,300,554 |
| 03/06/25 | 2.73 | 2.79 | 2.62 | 2.71 | 8,402,949 |
| 02/06/25 | 2.765 | 2.88 | 2.65 | 2.67 | 12,149,775 |
|
|
||||
|
|
||||
|
|